Streetwise Medical Devices Articles


Agreement Facilitates Progress Toward Medical Device Approvals

  ()
This medical device company enters a partnership to provide quality and regulatory services. read more >

Coverage Initiated on Developer of Women's Reproductive Health Products

Research Report
  ()
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. read more >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'

Research Report
  ()
Cowen analyst Dr. Joshua Jennings highlighted this medical device firmís Q1/18 developments and financial results. read more >

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease

  ()
In the second of a two-part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small-cap companies targeting big-ticket indications and their potential to drive blockbuster value for both patients and investors. read more >

Medical Device Firm Posts 'Strong Performance' Globally in Q4/17

Research Report
  ()
The company performed strongly in the U.S. and the Asia Pacific region. read more >

Convergence Will Drive the Ultimate Disruption of Life Sciences

Contributed Opinion
  ()
Andrea Bartzen, a strategic commercial and communication consultant, describes the disruptive technologies positioned to radically alter the business of life sciences as discussed at a recent BIO CEO Summit Investor Night. read more >

Medical Device Firm to Launch Trials for Treatment Targeting $12 Billion Incontinence Market

Research Report
  ()
Anthony Vendetti, an analyst with Maxim Group, shared the results both of a pilot study for stress urinary incontinence and of a recent equity raise by this company. read more >

Medical Device Firm Boosts Quarterly Revenue 50% YOY

Research Report
  ()
A Maxim Group report noted the recently announced revenue achieved and anticipated by this producer of cancer treatment devices. read more >

Firm Focused on Women's Health Posts 'Record' Sales of Treatment Device

  ()
A company marketing a product designed to enhance women's sexual function announced preliminary financial results for Q4/17 that caught the attention of several analysts. read more >

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA

Research Report
  ()
Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery and will measure its effectiveness in reducing a common post-surgical side effect. read more >
Showing Results: 1 to 10 of 10

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe